APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pre-Exposure Prophylaxis

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pre-Exposure Prophylaxis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025171 pages

Choose your research edition.

Industry ResearchPre-Exposure Prophylaxis Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Pre-Exposure Prophylaxis Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Pre-Exposure Prophylaxis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pre-Exposure Prophylaxis Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pre-Exposure Prophylaxis Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Pre-Exposure Prophylaxis market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pre-Exposure Prophylaxis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pre-Exposure Prophylaxis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pre-Exposure Prophylaxis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pre-Exposure Prophylaxis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pre-Exposure Prophylaxis include Gilead Sciences, Lupin, Strides Pharma Science and Teva Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pre-Exposure Prophylaxis market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pre-Exposure Prophylaxis and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pre-Exposure Prophylaxis sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pre-Exposure Prophylaxis market size, projected growth trends, production technologies, key applications, and end-use industries.

Pre-Exposure Prophylaxis Segment by Company

Gilead Sciences

Lupin

Strides Pharma Science

Teva Pharmaceuticals

Pre-Exposure Prophylaxis Segment by Type

Truvada

Discovy

Pre-Exposure Prophylaxis Segment by Application

Adult

Adolescent

Pre-Exposure Prophylaxis Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pre-Exposure Prophylaxis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pre-Exposure Prophylaxis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pre-Exposure Prophylaxis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pre-Exposure Prophylaxis market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pre-Exposure Prophylaxis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pre-Exposure Prophylaxis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pre-Exposure Prophylaxis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pre-Exposure Prophylaxis Industry Trends Table 2. Pre-Exposure Prophylaxis Industry Drivers Table 3. Pre-Exposure Prophylaxis Industry Opportunities and Challenges Table 4. Pre-Exposure Prophylaxis Industry Restraints Table 5. Global Pre-Exposure Prophylaxis Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pre-Exposure Prophylaxis Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pre-Exposure Prophylaxis Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Pre-Exposure Prophylaxis Sales Market Share by Manufacturers Table 9. Global Pre-Exposure Prophylaxis Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Pre-Exposure Prophylaxis Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pre-Exposure Prophylaxis Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pre-Exposure Prophylaxis Manufacturers, Product Type & Application Table 13. Global Pre-Exposure Prophylaxis Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pre-Exposure Prophylaxis by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Truvada Table 17. Major Manufacturers of Discovy Table 18. Global Pre-Exposure Prophylaxis Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Pre-Exposure Prophylaxis Sales by Type (2021-2026) & (K Units) Table 20. Global Pre-Exposure Prophylaxis Sales by Type (2027-2032) & (K Units) Table 21. Global Pre-Exposure Prophylaxis Sales Market Share by Type (2021-2026) Table 22. Global Pre-Exposure Prophylaxis Sales Market Share by Type (2027-2032) Table 23. Global Pre-Exposure Prophylaxis Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Pre-Exposure Prophylaxis Revenue by Type (2021-2026) & (K Units) Table 25. Global Pre-Exposure Prophylaxis Revenue by Type (2027-2032) & (K Units) Table 26. Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2021-2026) Table 27. Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Adult Table 29. Major Manufacturers of Adolescent Table 30. Global Pre-Exposure Prophylaxis Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Pre-Exposure Prophylaxis Sales by Application (2021-2026) & (K Units) Table 32. Global Pre-Exposure Prophylaxis Sales by Application (2027-2032) & (K Units) Table 33. Global Pre-Exposure Prophylaxis Sales Market Share by Application (2021-2026) Table 34. Global Pre-Exposure Prophylaxis Sales Market Share by Application (2027-2032) Table 35. Global Pre-Exposure Prophylaxis Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Pre-Exposure Prophylaxis Revenue by Application (2021-2026) & (K Units) Table 37. Global Pre-Exposure Prophylaxis Revenue by Application (2027-2032) & (K Units) Table 38. Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2021-2026) Table 39. Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2027-2032) Table 40. Global Pre-Exposure Prophylaxis Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Pre-Exposure Prophylaxis Sales by Region (2021-2026) & (K Units) Table 42. Global Pre-Exposure Prophylaxis Sales Market Share by Region (2021-2026) Table 43. Global Pre-Exposure Prophylaxis Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Pre-Exposure Prophylaxis Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Pre-Exposure Prophylaxis Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Pre-Exposure Prophylaxis Sales by Country (2021-2026) & (K Units) Table 47. North America Pre-Exposure Prophylaxis Sales by Country (2027-2032) & (K Units) Table 48. Europe Pre-Exposure Prophylaxis Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Pre-Exposure Prophylaxis Sales by Country (2021-2026) & (K Units) Table 50. Europe Pre-Exposure Prophylaxis Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Pre-Exposure Prophylaxis Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Pre-Exposure Prophylaxis Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Pre-Exposure Prophylaxis Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Pre-Exposure Prophylaxis Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Pre-Exposure Prophylaxis Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Pre-Exposure Prophylaxis Sales by Country (2027-2032) & (K Units) Table 57. Global Pre-Exposure Prophylaxis Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Pre-Exposure Prophylaxis Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Pre-Exposure Prophylaxis Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Pre-Exposure Prophylaxis Revenue Market Share by Region (2021-2026) Table 61. Global Pre-Exposure Prophylaxis Revenue Market Share by Region (2027-2032) Table 62. Gilead Sciences Company Information Table 63. Gilead Sciences Business Overview Table 64. Gilead Sciences Pre-Exposure Prophylaxis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Gilead Sciences Pre-Exposure Prophylaxis Product Portfolio Table 66. Gilead Sciences Recent Development Table 67. Lupin Company Information Table 68. Lupin Business Overview Table 69. Lupin Pre-Exposure Prophylaxis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Lupin Pre-Exposure Prophylaxis Product Portfolio Table 71. Lupin Recent Development Table 72. Strides Pharma Science Company Information Table 73. Strides Pharma Science Business Overview Table 74. Strides Pharma Science Pre-Exposure Prophylaxis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Strides Pharma Science Pre-Exposure Prophylaxis Product Portfolio Table 76. Strides Pharma Science Recent Development Table 77. Teva Pharmaceuticals Company Information Table 78. Teva Pharmaceuticals Business Overview Table 79. Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Teva Pharmaceuticals Pre-Exposure Prophylaxis Product Portfolio Table 81. Teva Pharmaceuticals Recent Development Table 82. Key Raw Materials Table 83. Raw Materials Key Suppliers Table 84. Pre-Exposure Prophylaxis Distributors List Table 85. Pre-Exposure Prophylaxis Customers List Table 86. Research Programs/Design for This Report Table 87. Authors List of This Report Table 88. Secondary Sources Table 89. Primary Sources List of Figures Figure 1. Pre-Exposure Prophylaxis Product Image Figure 2. Global Pre-Exposure Prophylaxis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pre-Exposure Prophylaxis Market Size (2021-2032) & (US$ Million) Figure 4. Global Pre-Exposure Prophylaxis Sales (2021-2032) & (K Units) Figure 5. Global Pre-Exposure Prophylaxis Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pre-Exposure Prophylaxis Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Truvada Image Figure 9. Discovy Image Figure 10. Global Pre-Exposure Prophylaxis Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Pre-Exposure Prophylaxis Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Pre-Exposure Prophylaxis Sales Market Share by Type (2021-2032) Figure 13. Global Pre-Exposure Prophylaxis Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Pre-Exposure Prophylaxis Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2021-2032) Figure 16. Adult Image Figure 17. Adolescent Image Figure 18. Global Pre-Exposure Prophylaxis Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Pre-Exposure Prophylaxis Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Pre-Exposure Prophylaxis Sales Market Share by Application (2021-2032) Figure 21. Global Pre-Exposure Prophylaxis Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Pre-Exposure Prophylaxis Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2021-2032) Figure 24. North America Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Pre-Exposure Prophylaxis Sales Market Share by Country (2021-2032) Figure 26. U.S. Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Pre-Exposure Prophylaxis Sales Market Share by Country (2021-2032) Figure 31. Germany Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Pre-Exposure Prophylaxis Sales Market Share by Country (2021-2032) Figure 38. China Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Pre-Exposure Prophylaxis Sales Market Share by Country (2021-2032) Figure 46. Brazil Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Pre-Exposure Prophylaxis Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Pre-Exposure Prophylaxis Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Pre-Exposure Prophylaxis Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Figure 57. North America Pre-Exposure Prophylaxis Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Figure 59. Europe Pre-Exposure Prophylaxis Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Pre-Exposure Prophylaxis Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Pre-Exposure Prophylaxis Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Pre-Exposure Prophylaxis Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Pre-Exposure Prophylaxis Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Pre-Exposure Prophylaxis Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Truvada
  • Discovy
Applications
  • Adult
  • Adolescent
Companies covered
  • Gilead Sciences
  • Lupin
  • Strides Pharma Science
  • Teva Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pre-Exposure Prophylaxis Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pre-Exposure Prophylaxis Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pre-Exposure Prophylaxis Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pre-Exposure Prophylaxis Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pre-Exposure Prophylaxis Market Dynamics
  1. 2.1 Pre-Exposure Prophylaxis Industry Trends
  2. 2.2 Pre-Exposure Prophylaxis Industry Drivers
  3. 2.3 Pre-Exposure Prophylaxis Industry Opportunities and Challenges
  4. 2.4 Pre-Exposure Prophylaxis Industry Restraints
3 Pre-Exposure Prophylaxis Market by Manufacturers
  1. 3.1 Global Pre-Exposure Prophylaxis Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pre-Exposure Prophylaxis Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pre-Exposure Prophylaxis Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pre-Exposure Prophylaxis Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pre-Exposure Prophylaxis Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pre-Exposure Prophylaxis Manufacturers, Product Type & Application
  7. 3.7 Global Pre-Exposure Prophylaxis Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pre-Exposure Prophylaxis Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pre-Exposure Prophylaxis Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pre-Exposure Prophylaxis Tier 1, Tier 2, and Tier 3
4 Pre-Exposure Prophylaxis Market by Type
  1. 4.1 Pre-Exposure Prophylaxis Type Introduction
  2. 4.1.1 Truvada
  3. 4.1.2 Discovy
  4. 4.2 Global Pre-Exposure Prophylaxis Sales by Type
  5. 4.2.1 Global Pre-Exposure Prophylaxis Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pre-Exposure Prophylaxis Sales by Type (2021-2032)
  7. 4.2.3 Global Pre-Exposure Prophylaxis Sales Market Share by Type (2021-2032)
  8. 4.3 Global Pre-Exposure Prophylaxis Revenue by Type
  9. 4.3.1 Global Pre-Exposure Prophylaxis Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pre-Exposure Prophylaxis Revenue by Type (2021-2032)
  11. 4.3.3 Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2021-2032)
5 Pre-Exposure Prophylaxis Market by Application
  1. 5.1 Pre-Exposure Prophylaxis Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Adolescent
  4. 5.2 Global Pre-Exposure Prophylaxis Sales by Application
  5. 5.2.1 Global Pre-Exposure Prophylaxis Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pre-Exposure Prophylaxis Sales by Application (2021-2032)
  7. 5.2.3 Global Pre-Exposure Prophylaxis Sales Market Share by Application (2021-2032)
  8. 5.3 Global Pre-Exposure Prophylaxis Revenue by Application
  9. 5.3.1 Global Pre-Exposure Prophylaxis Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Pre-Exposure Prophylaxis Revenue by Application (2021-2032)
  11. 5.3.3 Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2021-2032)
6 Global Pre-Exposure Prophylaxis Sales by Region
  1. 6.1 Global Pre-Exposure Prophylaxis Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pre-Exposure Prophylaxis Sales by Region (2021-2032)
  3. 6.2.1 Global Pre-Exposure Prophylaxis Sales by Region (2021-2026)
  4. 6.2.2 Global Pre-Exposure Prophylaxis Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pre-Exposure Prophylaxis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pre-Exposure Prophylaxis Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pre-Exposure Prophylaxis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pre-Exposure Prophylaxis Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pre-Exposure Prophylaxis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pre-Exposure Prophylaxis Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pre-Exposure Prophylaxis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pre-Exposure Prophylaxis Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pre-Exposure Prophylaxis Revenue by Region
  1. 7.1 Global Pre-Exposure Prophylaxis Revenue by Region
  2. 7.1.1 Global Pre-Exposure Prophylaxis Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pre-Exposure Prophylaxis Revenue by Region (2021-2026)
  4. 7.1.3 Global Pre-Exposure Prophylaxis Revenue by Region (2027-2032)
  5. 7.1.4 Global Pre-Exposure Prophylaxis Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pre-Exposure Prophylaxis Revenue (2021-2032)
  8. 7.2.2 North America Pre-Exposure Prophylaxis Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pre-Exposure Prophylaxis Revenue (2021-2032)
  11. 7.3.2 Europe Pre-Exposure Prophylaxis Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pre-Exposure Prophylaxis Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pre-Exposure Prophylaxis Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pre-Exposure Prophylaxis Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pre-Exposure Prophylaxis Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Gilead Sciences
  2. 8.1.1 Gilead Sciences Company Information
  3. 8.1.2 Gilead Sciences Business Overview
  4. 8.1.3 Gilead Sciences Pre-Exposure Prophylaxis Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Gilead Sciences Pre-Exposure Prophylaxis Product Portfolio
  6. 8.1.5 Gilead Sciences Recent Developments
  7. 8.2 Lupin
  8. 8.2.1 Lupin Company Information
  9. 8.2.2 Lupin Business Overview
  10. 8.2.3 Lupin Pre-Exposure Prophylaxis Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Lupin Pre-Exposure Prophylaxis Product Portfolio
  12. 8.2.5 Lupin Recent Developments
  13. 8.3 Strides Pharma Science
  14. 8.3.1 Strides Pharma Science Company Information
  15. 8.3.2 Strides Pharma Science Business Overview
  16. 8.3.3 Strides Pharma Science Pre-Exposure Prophylaxis Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Strides Pharma Science Pre-Exposure Prophylaxis Product Portfolio
  18. 8.3.5 Strides Pharma Science Recent Developments
  19. 8.4 Teva Pharmaceuticals
  20. 8.4.1 Teva Pharmaceuticals Company Information
  21. 8.4.2 Teva Pharmaceuticals Business Overview
  22. 8.4.3 Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Teva Pharmaceuticals Pre-Exposure Prophylaxis Product Portfolio
  24. 8.4.5 Teva Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pre-Exposure Prophylaxis Value Chain Analysis
  2. 9.1.1 Pre-Exposure Prophylaxis Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pre-Exposure Prophylaxis Production Mode & Process
  6. 9.2 Pre-Exposure Prophylaxis Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pre-Exposure Prophylaxis Distributors
  9. 9.2.3 Pre-Exposure Prophylaxis Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst